Trump Corruption Claims May Shape Investor Sentiment Amid Political Uncertainty US Stocks Open Higher as AI Momentum and Mideast Truce Hopes Lift Sentiment Trump Signals Iran War Agreement Largely Negotiated Pakistan Officials Cite Encouraging Progress Honda Announces Ambitious Plans 10 New Cars by 2030 Including Updated City Starting at Rs12 Lakh AI Talent Arms Race Tech Giants Pay Millions in Salaries Billions in Equity to Secure Top Researchers SP 500 Notches Record Close as AI Optimism Drives Micron to 1 Trillion Market Cap Sight Sciences Inc SGHT Q1 2026 Earnings EPS Misses Estimates as Operating Losses Widen Revvity Q1 2026 Earnings EPS Surpasses Consensus Stock Slips on Missing Revenue Details MRVI Q1 2026 Earnings Small Profit Surpasses Street Expectations as Sales Data Remains Withheld Loop Industries Q1 2026 Earnings Narrowerthanexpected loss amid steady technology development TATT Q1 2026 Earnings EPS Surges Past Estimates with 33 Beat CYH Q1 2026 Earnings Significant EPS Miss Amid Operational Challenges Pacific Biosciences PACB Edges Higher But Key Resistance Remains a Hurdle BeLive Holdings BLIV Consolidates Near Support as Stock Trades Flat EVGOW Warrants Trade at Penny Level as Downside Pressure Continues CorMedix Inc CRMD Edges Lower as Stock Tests Key Support Near 758 STAK Inc STAK Declines 455 as Stock Hovers Near Key 10 Support Level TechDriven Rally Lifts SP 500 as Dow Pauses Energy Slumps PRDO Q1 2026 Earnings Profit Beats Expectations as Company Delivers Strong EPS Surprise SL Green Realty SLG Holds Near Support as Office Sector Navigates Uncertainty NRX Pharmaceuticals Q1 2026 Earnings Wider Loss Despite No Revenue Stock Advances PZG Q1 2026 Earnings Significant EPS Miss Amid PreRevenue Phase AMCX Q1 2026 Earnings Profitability Falls Short as CordCutting Pressures Persist PennantPark Investment Corp PNNT Q1 2026 Earnings EPS Misses Estimates Amid Stable Portfolio Performance ESS Q1 2026 Earnings EPS Beat Lifts Shares Amid Steady Apartment Demand AEON Biopharma Q4 2025 Earnings Major EPS Miss and No Revenue Weigh on Investor Sentiment INMB Q4 2025 Earnings Narrowing Losses Amid Clinical Pipeline Progress